insulin
Showing 1 - 25 of >10,000
Diabetes Trial (Insulin Degludec and Insulin Aspart)
Not yet recruiting
- Diabetes
- Insulin Degludec and Insulin Aspart
- (no location specified)
Apr 4, 2023
Insulin Pump,Continuous Glucose Monitoring Technology Trial in Guandong (Insulin Glargine, Metformin, Dapagliflozin)
Recruiting
- Insulin Pump,Continuous Glucose Monitoring Technology
- Insulin Glargine
- +3 more
-
Guandong, China刘烈华
Nov 7, 2023
Diabetes, Type 1 Trial (Afrezza, insulin degludec, Rapid-acting Insulin Analog)
Not yet recruiting
- Diabetes Mellitus, Type 1
- Afrezza
- +3 more
- (no location specified)
Jun 6, 2023
Asthma, Obesity, Insulin Resistance Trial in Birmingham (Probiotic, Placebo)
Not yet recruiting
- Asthma
- +2 more
- Probiotic
- Placebo
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jul 7, 2023
Type 2 Diabetes Trial in Charlottesville (Control-IQ use in Type 2 Diabetes under basal insulin injections)
Not yet recruiting
- Type 2 Diabetes
- Control-IQ use in Type 2 Diabetes under basal insulin injections
-
Charlottesville, VirginiaUniversity of Virginia Center for Diabetes Technology
Sep 5, 2023
Insulin Resistance in Egyptian Patients With Multiple Sclerosis
Not yet recruiting
- Multiple Sclerosis
- Insulin Resistance
- treatment of insulin resistance with appropriate modality according to each patient
- (no location specified)
Aug 28, 2023
Insulin Resistance Trial (Total body vibration, moderate restricted diet)
Not yet recruiting
- Insulin Resistance
- Total body vibration
- moderate restricted diet
- (no location specified)
Jul 25, 2023
Type 2 Diabetes Treated With Insulin Trial in Izmir (INS-MOBILE: Mobile Application Developed for Insulin Use)
Completed
- Type 2 Diabetes Treated With Insulin
- INS-MOBILE: Mobile Application Developed for Insulin Use
-
İzmir, Bornova, TurkeyEge University
Sep 25, 2023
Alcohol Use Disorder Trial (Regular Human Insulin then Placebo, Placebo then Regular Human Insulin)
Not yet recruiting
- Alcohol Use Disorder
- Regular Human Insulin then Placebo
- Placebo then Regular Human Insulin
- (no location specified)
Aug 9, 2023
To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children Trial in
Completed
- To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children
- Glargine and regular insulin versus NPH and regular insulin
-
Lahore, Punjab, PakistanPediatric endocrine and diabetes section, Pediatric department,
Jan 29, 2023
Metabolic Syndrome Trial in Guadalajara (Celery Seed, Placebo)
Recruiting
- Metabolic Syndrome
- Celery Seed
- Placebo
-
Guadalajara, Jalisco, MexicoINSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA. Centro Universi
Sep 25, 2023
Gestational Diabetes, Pregnancy in Diabetic, Pregnancy, High Risk Trial in Columbus (Patient-led Insulin (intervention group),
Not yet recruiting
- Gestational Diabetes Mellitus
- +2 more
- Patient-led Insulin (intervention group)
- Provider-led Insulin (standard care)
-
Columbus, OhioThe Ohio State University Wexner Medical Center OB/GYN Maternal
Jun 26, 2023
Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)
Recruiting
- Diabetes Mellitus, Type 2 Treated With Insulin
- insulin degludec + liraglutide
- Insulin Glargine - Insulin Aspart
-
Bogotá, ColombiaHospital Universitario San Ignacio
Mar 2, 2023
Alzheimer, Mild Cognitive Impairment, Positron Emission Tomography Trial in Turku (FDG-PET study)
Recruiting
- Alzheimer Disease
- +2 more
- FDG-PET study
-
Turku, FinlandTurku PET Centre
Oct 30, 2023
Scars, Insulin Trial in Alexandria (Microneedling with topical application of regular insulin, Microneedling with topical
Recruiting
- Scars
- Insulin
- Microneedling with topical application of regular insulin
- Microneedling with topical application of saline
-
Alexandria, EgyptAlexandria University, Faculty of Medicine
Sep 7, 2023
Insulin Resistance, Polycystic Ovary Syndrome, Hyperinsulinism Trial in Houston
Not yet recruiting
- Insulin Resistance
- +4 more
-
Houston, TexasLilli Health
Jul 10, 2023
type1diabetes, Diabetes, Type 1 Trial in Montreal (Pramlintide, Insulin Lispro, Insulin aspart)
Not yet recruiting
- type1diabetes
- Diabetes Mellitus, Type 1
- Pramlintide
- +3 more
-
Montreal, Quebec, CanadaResearch Institute of the McGill University Health Center
Sep 18, 2023
Insulin Resistance, Obesity Trial in Tübingen (single bout of moderate intensity continuous training (MICT), single bout of High
Not yet recruiting
- Insulin Resistance
- Obesity
- single bout of moderate intensity continuous training (MICT)
- +2 more
-
Tübingen, GermanyUniversity Clinic Tübingen, Department of Internal Medicine IV
Sep 13, 2023
Obesity, Exercise Trial in Columbia (exercise)
Not yet recruiting
- Obesity
- Exercise
- exercise
-
Columbia, MissouriUniversity of Misouri
Jul 3, 2023
Central Insulin Resistance, Diabetes, Type 2, PreDiabetes Trial (Human nasal insulin, Placebo)
Not yet recruiting
- Central Insulin Resistance
- +2 more
- Human nasal insulin
- Placebo
- (no location specified)
May 12, 2023
Insulin Resistance Trial (radiofrquency device)
Not yet recruiting
- Insulin Resistance
- radiofrquency device
- (no location specified)
Apr 17, 2023
Type 1 Diabetes, Type 2 Diabetes, Hyperglycemia Trial in Winston-Salem (Libre 2.0 CGM in patients taking subcutaneous insulin
Not yet recruiting
- Type 1 Diabetes Mellitus
- +2 more
- Libre 2.0 CGM in patients taking subcutaneous insulin with concomitant high dose glucocorticoids
-
Winston-Salem, North CarolinaWakeForest University Health Sciences
May 11, 2023
Long COVID, Insulin Resistance, Insulin Sensitivity Trial in Palo Alto (Adipose Tissue Biopsy, Steady State Plasma Glucose
Not yet recruiting
- Long COVID
- +2 more
- Adipose Tissue Biopsy
- Steady State Plasma Glucose (SSPG) Test
-
Palo Alto, California
- +1 more
Apr 27, 2023
Diabetes, Critical Illness, Hyperglycemia Trial in Riyadh (Degludec insulin)
Recruiting
- Diabetes Mellitus
- +2 more
- Degludec insulin
-
Riyadh, Saudi ArabiaKing Faisal Specialist Hospital & Research Centre
Sep 24, 2023